Other Links
About Us
Situated in Cyprus, Remedica is a leading pharmaceutical company with a global reach extending to over 140 countries. Since our foundation in 1980, we have undergone a dynamic revolution, culminating in a specialized focus on the development, production and distribution of high-quality, safe and efficacious medicinal products for human use. We market a diverse range of healthcare products, boasting a robust pharmaceutical assortment of over 300 generics, branded generic, and over-the-counter (OTC) products.
Our product catalogue encompasses many therapeutic areas, spanning antivirals, antineoplastic, cardiovascular, central nervous system, gastrointestinal, respiratory tract, dermatological agents and anti-infective products. At present, Remedica operates three cutting-edge facilities, each rigorously inspected and approved by health authorities from numerous States on a European and Global level, such as Cyprus, Germany, the United Kingdom, Denmark, Australia, Brazil, Japan, and countless others, reinforcing Remedica’s commitment to uncompromising quality and safety. Our headquarters and manufacturing site are located in Cyprus. Additionally, we maintain a Representative Office in UAE, Scientific Offices in Saudi Arabia and Vietnam, and Sales offices in Greece and Kenya.
We are a global generics company dedicated to improving the health and well-being of individuals, communities, and healthcare systems. Our enduring commitment is to be people-centric, focusing on health and humanity, and empowering individuals worldwide to live healthier lives at every stage.
At Remedica, our culture thrives on collaboration and a collective commitment to enhancing patient lives globally. Our success is deeply rooted in the passion and dedication of our people, who unite to push the boundaries of science and medicine.
We relentlessly pursue excellence, setting the highest standards in every aspect of our work. Beyond our medicines, we are dedicated to making a positive impact by engaging with the communities we serve, actively participating in initiatives that promote health, education, and social responsibility.
Export Countries
Markets with robust commercial presence
Products
Buildings
Factories
Square meters
Employee
We are proud to be recognised for our commitment to excellence and quality, setting the standards in the generic pharmaceutical industry. Our awards are a testament to the dedication of our people to enhancing accessibility and affordability in healthcare and making a difference to millions of patients around the world.
1989, 1995, 1998, 2000, 2004, 2006, 2009, 2014, 2018, 2022
2014 One of the top 10 best export/import companies across Europe 2018 National Winner 2019 National Winner
2018, 2019, 2020, 2022, 2023
2024
2017, 2022
2019, 2020, 2021
2019
Successful GMP inspection by Brazilian Authorities ANVISA and UNICEF/MSF/ICRC Non-Profit Organisations
Successful GMP inspection by the Japanese (PMDA) & Kenyan (PPB) Authorities
Successful GMP inspection by Iranian Authorities (IFDA)
Successful GMP inspection by Nigerian (NAFDAC) & Sudanese Authorities
Successful GMP inspection by Gulf Cooperation Council Authorities (GCC) and UNICEF/MSF/ICRC Non-Profit Organisations
Successful GMP inspection by Tanzanian (TFDA) and Libyan Authorities
Successful GMP inspection by Russian Authorities
Successful campaign inspection by the Senior Labour lnspectors Committee (SLIC) of the European Commission
Successful GMP inspection by Belarusian Authorities and UNICEF/MSF/ICRC Non-Profit Organisations
Successful GMP inspection by the New Zealand Health Authorities (MEDSAFE)
Successful GMP inspection by Kingdom of Saudi Arabia Health Authorities (SFDA)
Successful Pharmaceutical Supply Chain Initiative (PSCI) audit on Ethics, Human Rights, Labour, Health and Safety, Environment, and Management Systems
Successful GMP inspection by the Yemen and Libyan Health Authorities
Successful GDP inspection by the Cyprus Ministry of Health